Lasarus
3 known investors
LASARRUS develops device-enabled solutions, including its WearME System, for remote monitoring and early detection of Chronic Obstructive Pulmonary Disease (COPD). The company targets healthcare providers and COPD patients in the U.S. through wearable medical devices for remote patient monitoring.
Investors · 3
Competitors · 1
by search overlapCompanies competing with Lasarus for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase ISTTR | 2021 | $256K |
| National Science Foundation | Phase ISTTR | 2019 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Lasarus do?
- LASARRUS develops device-enabled solutions, including its WearME System, for remote monitoring and early detection of Chronic Obstructive Pulmonary Disease (COPD). The company targets healthcare providers and COPD patients in the U.S. through wearable medical devices for remote patient monitoring.
- Who are Lasarus's investors?
- Lasarus's investors include Atlanta Technology Angels, Maryland TEDCO, TEDCO.